Metagenomi science chief departs, just a few months after IPO

The chief sci­en­tif­ic of­fi­cer at gene edit­ing com­pa­ny Metageno­mi is out, the com­pa­ny con­firmed to End­points News.

“As of yes­ter­day, I have part­ed ways with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Why Buy Cannabis Stocks

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

Read More »